The M1 muscarinic acetylcholine receptor (mAChR) has emerged as an attractivemolecular target to overcome cognitive decline associated with cholinergic degenerationin Alzheimer disease (AD) (Anagnostaras et al.,2003). The gene discussed is CHRM1; the disease is Alzheimer disease.